1.Hugh SS，Havmoeller R，Narayanan K，et al. Worldwide epidemiology of atr ialfibrillation：a Global Burden of Disease 2010 Study［J］. Circulation，2014，129（8）：837-847.

2.Guo Y，TJan Y，Wang H，et al.Prevalence，incidence，and lifetime risk of atrial fibrillation in China：new insights into the global burden of atrial fibrillation ［J］ . Chest，2015，147（1）：109-119.

3.Guo Y，Wu Q，Zhang L，et al. Antithrombotic therapy in very elderly patients with atrial fibrillation：is it enough to assess thromboembolic risk［J］. Clin Interv Aging，2010，5（4）：157-162.

4.CammAJ，Kirchhof P，Lip GY，et al. Guidelines for the management of atrial fibrillation：the task force for the management of atrialfibrillation of the European Society of Cardiology（ESC）［J］. Eur Heart J，2010，31（19）：2369- 2429.

5.January CT，Wann LS，Al pert JS，et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrialfibrilation：a report of the Ameri can College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society Circulation ［J］. JACC，2014，130（23）：e199-267.

6.National Clinical Guideline Centre（UK）. Atrial fibrillation：the management of atrialfibrillation［M］. London：National Institute for Heahh and Care Excel l ence（UK），2014.

7.GuoY，Apostolakis S，Blann AD，et al. Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation［J］. Int J Cardiol，2013，168（2）：904-909.

8.中华医学会神经病学分会，中华医学会神经病学分会神经血管介入协作组，急性缺血性脑卒中介入诊疗指南撰写组.中国急性缺血性脑卒中早期血管内介入诊疗指南.中华神经内科杂志，2015，48（05）：356-361.